BiotechTube

Cannabidiol + Placebos

Phase 1/2Completed
0 watching 0 views this week💤 Quiet
36
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Alcohol Use Disorder

Conditions

Alcohol Use Disorder, Post Traumatic Stress Disorder

Trial Timeline

Sep 16, 2019 → Apr 20, 2022

NCT ID
NCT03248167

About Cannabidiol + Placebos

Cannabidiol + Placebos is a phase 1/2 stage product being developed by Tilray for Alcohol Use Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT03248167. Target conditions include Alcohol Use Disorder, Post Traumatic Stress Disorder.

Hype Score Breakdown

Clinical
13
Activity
8
Company
5
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT03248167Phase 1/2Completed

Competing Products

20 competing products in Alcohol Use Disorder

See all competitors
ProductCompanyStageHype Score
VK2809 + PlacebosViking TherapeuticsPhase 2
47
TERN-501 + TERN-101Terns PharmaceuticalsPhase 2
49
TERN-101Terns PharmaceuticalsPhase 2
49
TERN-201Terns PharmaceuticalsPhase 1
30
IVA337 + IVA337 + PlaceboInventivaPhase 2
47
LanifibranorInventivaPhase 2
47
IVA337 + Placebo + EmpagliflozinInventivaPhase 2
47
IVA337 + PlaceboInventivaPhase 3
72
LY686017 + PlaceboEli LillyPhase 2
52
LY3537031 + PlaceboEli LillyPhase 3
77
AD04 (ondansetron) + Matching placeboAdial PharmaceuticalsPhase 3
69
GODEX + PlaceboCelltrionPhase 3
77
Colesevelam HclDaiichi SankyoPhase 2
52
ASP9831 + PlaceboAstellas PharmaPhase 2
52
ASP8062 + PlaceboAstellas PharmaPhase 2
52
LY686017 + PlaceboEli LillyPhase 2
52
Mazdutide + PlaceboEli LillyPhase 2
52
opioid receptor kappa antagonistEli LillyPhase 1
33
Tirzepatide + PlaceboEli LillyPhase 2
52
LY2196044 + placeboEli LillyPhase 2
52

Other Products from Tilray

Cannabidiol (CBD) Oil Capsules + Sunflower Lecithin Oil in CapsulePhase 3
72
TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg) + TN-C200M2 oral capsules (CBD 200 mg)Phase 2
47
High THC/Low CBD Cannabis + High THC/High CBD Cannabis + Low THC/Low CBD CannabisPhase 2
47
TN-TC11G + Temozolomide Oral ProductPhase 1/2
36
Phytocannabinoid cannabidiol (CBD)Phase 1/2
36